You can access the annual and quarterly cash flow statements of LB Pharmaceuticals Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---3.37M
Net income from continuing operations
---3.56M
Operating gains losses
--81.00K
Other non-cash items
--45.00K
Change in working capital
---97.00K
-Change in prepaid expenses
---1.37M
-Change in payables and accrued expense
--1.57M
Cash from non-recurring investing activities
Cash from operating activities
---3.37M
Investing cash flow
Net cash from continuing investing activities
--0.00
Capital expenditures
--0.00
Net cash flow from disposal of fixed assets
--0.00
Net cash flow from investment products
---44.84M
Net cash flow from other investing activities
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
---44.84M
Financing cash flow
Cash flow from continuous financing activities
--303.73M
Net cash flow from common stock issuance/repurchase
--327.75M
Net cash flow from preferred stock issuance/repurchase
--0.00
Proceeds from stock option exercised by employees
--247.00K
Net cash flow from other financing activities
---24.27M
Net cash from non-recurrent financing activities
Net cash from financing activities
--303.73M
Net cash flow
Beginning cash balance
--14.73M
Current period cash flow changes
--255.52M
Ending cash balance
--270.26M
Free cash flow
---3.37M
Currency unit
USD
Audit opinions
--
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.